Epigenetic regulation of satellite cell activation during muscle regeneration

Stem Cell Research and Therapy

Volumn 2, Issue 2, 2011, Pages

  Dilworth, F Jeffrey ^a,b   Blais, Alexandre ^b,c  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE METHYLTRANSFERASE; LYSINE METHYLTRANSFERASE FAMILY 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MUSCLE PROTEIN; POLYCOMB GROUP PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EZH1; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTION FACTOR YY1; TRITHORAX GROUP PROTEIN; UNCLASSIFIED DRUG; MYOD PROTEIN; MYOGENIC FACTOR 5; MYOGENIN; PAX7 PROTEIN, HUMAN;

CELL ACTIVATION; CELL CYCLE PROGRESSION; CHROMATIN STRUCTURE; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC EPIGENESIS; GENETIC MARKER; GENETIC SCREENING; HISTONE METHYLATION; HUMAN; INTRACELLULAR SIGNALING; MUSCLE CREATINE KINASE GENE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYF5 GENE; MYOD GENE; MYOG GENE; NONHUMAN; NONMUSCLE TYPE MYOSIN HEAVY POLYPEPTIDE 10 GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATOR GENE; REVIEW; SILENCER GENE; SKELETAL MUSCLE SATELLITE CELL; TRANSCRIPTION REGULATION; UPREGULATION; CYTOLOGY; EPIGENETICS; METABOLISM; MUSCLE DEVELOPMENT; PHYSIOLOGY; REGENERATION;

DNA METHYLATION; EPIGENOMICS; HUMANS; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHIES; MYOD PROTEIN; MYOGENIC REGULATORY FACTOR 5; MYOGENIN; PAX7 TRANSCRIPTION FACTOR; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE;

EID: 80052410699     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt59     Document Type: Review

References (71)

1. Satellite cell of skeletal muscle fibers. Mauro A, J Biophys Biochem Cytol 1961 9 493 495 10.1083/jcb.9.2.493 13768451
2. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Peault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, Partridge T, Gussoni E, Kunkel LM, Huard J, Mol Ther 2007 15 867 877 10.1038/mt.sj.6300145 17387336 (Pubitemid 46621645)
3. Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Mitchell KJ, Pannerec A, Cadot B, Parlakian A, Besson V, Gomes ER, Marazzi G, Sassoon DA, Nat Cell Biol 2010 12 257 266 20118923
4. Cellular and molecular regulation of muscle regeneration. Charge SB, Rudnicki MA, Physiol Rev 2004 84 209 238 10.1152/physrev.00019.2003 14715915 (Pubitemid 38049880)
5. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Kuang S, Kuroda K, Le Grand F, Rudnicki MA, Cell 2007 129 999 1010 10.1016/j.cell.2007.03.044 17540178 (Pubitemid 46802699)
6. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Le Grand F, Jones AE, Seale V, Scime A, Rudnicki MA, Cell Stem Cell 2009 4 535 547 10.1016/j.stem.2009.03.013 19497282
7. Interpretation of developmental signaling at chromatin: the Polycomb perspective. Sawarkar R, Paro R, Dev Cell 2010 19 651 661 10.1016/j.devcel.2010. 10.012 21074716
8. Polycomb group protein-mediated repression of transcription. Morey L, Helin K, Trends Biochem Sci 2010 35 323 332 10.1016/j.tibs.2010.02.009 20346678
9. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, Stadler MB, Bibel M, Schubeler D, Mol Cell 2008 30 755 766 10.1016/j.molcel.2008.05.007 18514006
10. A model for transmission of the H3K27me3 epigenetic mark. Hansen KH, Bracken AP, Pasini D, Dietrich N, Gehani SS, Monrad A, Rappsilber J, Lerdrup M, Helin K, Nat Cell Biol 2008 10 1291 1300 10.1038/ncb1787 18931660
11. High-resolution profiling of histone methylations in the human genome. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K, Cell 2007 129 823 837 10.1016/j.cell.2007.05.009 17512414 (Pubitemid 46802390)
12. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, Issaeva I, Canaani E, Salcini AE, Helin K, Nature 2007 449 731 734 10.1038/nature06145 17713478 (Pubitemid 47552088)
13. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G, Cell 2007 130 1083 1094 10.1016/j.cell.2007.08.019 17825402 (Pubitemid 47410272)
14. A histone H3 lysine 27 demethylase regulates animal posterior development. Lan F, Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S, Iwase S, Alpatov R, Issaeva I, Canaani E, Roberts TM, Chang HY, Shi Y, Nature 2007 449 689 694 10.1038/nature06192 17851529 (Pubitemid 47552096)
15. Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice. Schuettengruber B, Cavalli G, Development 2009 136 3531 3542 10.1242/dev.033902 19820181
16. Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures. Reimann J, Brimah K, Schroder R, Wernig A, Beauchamp JR, Partridge TA, Cell Tissue Res 2004 315 233 242 10.1007/s00441-003-0833-y 14648195 (Pubitemid 38657430)
17. TNF/p38/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V, Marquez VE, Valente S, Mai A, Forcales SV, Sartorelli V, Puri PL, Cell Stem Cell 2010 7 455 469 10.1016/j.stem.2010.08.013 20887952
18. 2expression, and promotes myogenic differentiation. Sebastian S, Sreenivas P, Sambasivan R, Cheedipudi S, Kandalla P, Pavlath GK, Dhawan J, Proc Natl Acad Sci USA 2009 106 4719 4724 10.1073/pnas.0807136106 19264965
19. Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. Blais A, van Oevelen CJ, Margueron R, Acosta-Alvear D, Dynlacht BD, J Cell Biol 2007 179 1399 1412 10.1083/jcb.200705051 18166651
20. E2F-associated chromatin modifiers and cell cycle control. Blais A, Dynlacht BD, Curr Opin Cell Biol 2007 19 658 662 10.1016/j.ceb.2007.10.003 18023996 (Pubitemid 350216425)
21. Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. McKinnell IW, Ishibashi J, Le Grand F, Punch VG, Addicks GC, Greenblatt JF, Dilworth FJ, Rudnicki MA, Nat Cell Biol 2008 10 77 84 10.1038/ncb1671 18066051
22. UTX mediates demethylation of H3K27me3 at musclespecific genes during myogenesis. Seenundun S, Rampalli S, Liu QC, Aziz A, Palii C, Hong S, Blais A, Brand M, Ge K, Dilworth FJ, Embo J 2010 29 1401 1411 10.1038/emboj.2010.37 20300060
23. Regulating a master regulator: establishing tissue-specific gene expression in skeletal muscle. Aziz A, Liu QC, Dilworth FJ, Epigenetics 2010 5 691 695 10.4161/epi.5.8.13045 20716948
24. p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Rampalli S, Li L, Mak E, Ge K, Brand M, Tapscott SJ, Dilworth FJ, Nat Struct Mol Biol 2007 14 1150 1156 10.1038/nsmb1316 18026121 (Pubitemid 350223328)
25. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V, Genes Dev 2004 18 2627 2638 10.1101/gad.1241904 15520282 (Pubitemid 39453102)
26. Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling. Moran JL, Li Y, Hill AA, Mounts WM, Miller CP, Physiol Genomics 2002 10 103 111 12181367 (Pubitemid 135707434)
27. An initial blueprint for myogenic differentiation. Blais A, Tsikitis M, Acosta-Alvear D, Sharan R, Kluger Y, Dynlacht BD, Genes Dev 2005 19 553 569 10.1101/gad.1281105 15706034 (Pubitemid 40314988)
28. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, MacQuarrie KL, Davison J, Morgan MT, Ruzzo WL, Gentleman RC, Tapscott SJ, Dev Cell 2010 18 662 674 10.1016/j.devcel.2010.02.014 20412780
29. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L, Nat Biotechnol 2010 28 511 515 10.1038/nbt.1621 20436464
30. TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy. Acharyya S, Sharma SM, Cheng AS, Ladner KJ, He W, Kline W, Wang H, Ostrowski MC, Huang TH, Guttridge DC, PLoS One 2010 5 12479 10.1371/journal.pone.0012479 20814569
31. Suz12 binds to silenced regions of the genome in a cell-type-specific manner. Squazzo SL, O'Geen H, Komashko VM, Krig SR, Jin VX, Jang SW, Margueron R, Reinberg D, Green R, Farnham PJ, Genome Res 2006 16 890 900 10.1101/gr.5306606 16751344 (Pubitemid 43992913)
32. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y, Sidow A, Wysocka J, Cell 2009 139 1290 1302 10.1016/j.cell.2009.12.002 20064375
33. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, Bak M, Tommerup N, Rappsilber J, Helin K, Nature 2010 464 306 310 10.1038/nature08788 20075857
34. Jarid2 and PRC2, partners in regulating gene expression. Li G, Margueron R, Ku M, Chambon P, Bernstein BE, Reinberg D, Genes Dev 2010 24 368 380 10.1101/gad.1886410 20123894
35. Molecular signature of quiescent satellite cells in adult skeletal muscle. Fukada S, Uezumi A, Ikemoto M, Masuda S, Segawa M, Tanimura N, Yamamoto H, Miyagoe-Suzuki Y, Takeda S, Stem Cells 2007 25 2448 2459 10.1634/stemcells. 2007-0019 17600112 (Pubitemid 47582737)
36. An adult tissue-specific stem cell in its niche: a gene profiling analysis of in vivo quiescent and activated muscle satellite cells. Pallafacchina G, Francois S, Regnault B, Czarny B, Dive V, Cumano A, Montarras D, Buckingham M, Stem Cell Res 2010 4 77 91 10.1016/j.scr.2009.10.003 19962952
37. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Lee MG, Villa R, Trojer P, Norman J, Yan KP, Reinberg D, Di Croce L, Shiekhattar R, Science 2007 318 447 450 10.1126/science.1149042 17761849 (Pubitemid 47614529)
38. Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo. Grifone R, Demignon J, Houbron C, Souil E, Niro C, Seller MJ, Hamard G, Maire P, Development 2005 132 2235 2249 10.1242/dev.01773 15788460 (Pubitemid 40744482)
39. Six proteins regulate the activation of Myf5 expression in embryonic mouse limbs. Giordani J, Bajard L, Demignon J, Daubas P, Buckingham M, Maire P, Proc Natl Acad Sci USA 2007 104 11310 11315 10.1073/pnas.0611299104 17592144 (Pubitemid 47175137)
40. Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site. Spitz F, Demignon J, Porteu A, Kahn A, Concordet JP, Daegelen D, Maire P, Proc Natl Acad Sci USA 1998 95 14220 14225 10.1073/pnas.95.24.14220 9826681 (Pubitemid 28549348)
41. Six1 and Six4 gene expression is necessary to activate the fast-type muscle gene program in the mouse primary myotome. Niro C, Demignon J, Vincent S, Liu Y, Giordani J, Sgarioto N, Favier M, Guillet-Deniau I, Blais A, Maire P, Dev Biol 2010 338 168 182 10.1016/j.ydbio.2009.11.031 19962975
42. Cooperation between myogenic regulatory factors and SIX family transcription factors is important for myoblast differentiation. Liu Y, Chu A, Chakroun I, Islam U, Blais A, Nucleic Acids Res 2010 38 6857 6871 10.1093/nar/gkq585 20601407
43. DNA methylation landscapes: provocative insights from epigenomics. Suzuki MM, Bird A, Nat Rev Genet 2008 9 465 476 10.1038/nrg2341 18463664 (Pubitemid 351693975)
44. Linking DNA methylation and histone modification: patterns and paradigms. Cedar H, Bergman Y, Nat Rev Genet 2009 10 295 304 10.1038/nrg2540 19308066
45. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Taylor SM, Jones PA, Cell 1979 17 771 779 10.1016/0092-8674(79) 90317-9 90553 (Pubitemid 9252286)
46. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Lassar AB, Paterson BM, Weintraub H, Cell 1986 47 649 656 10.1016/0092-8674(86)90507-6 2430720 (Pubitemid 17011408)
47. Inhibition of DNA methylation is involved in transdifferentiation of myoblasts into smooth muscle cells. Lee WJ, Kim HJ, Mol Cells 2007 24 441 444 18182862
48. Genomescale DNA methylation maps of pluripotent and differentiated cells. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, Lander ES, Nature 2008 454 766 770 18600261
49. The Polycomb group protein EZH2 directly controls DNA methylation. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, Bollen M, Esteller M, Di Croce L, de Launoit Y, Fuks F, Nature 2006 439 871 874 10.1038/nature04431 16357870 (Pubitemid 43255707)
50. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES, Cell 2006 125 315 326 10.1016/j.cell.2006.02.041 16630819
51. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H, Tempst P, Lin SP, Allis CD, Cheng X, Bestor TH, Nature 2007 448 714 717 10.1038/nature05987 17687327 (Pubitemid 47236857)
52. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Jia D, Jurkowska RZ, Zhang X, Jeltsch A, Cheng X, Nature 2007 449 248 251 10.1038/nature06146 17713477 (Pubitemid 47402375)
53. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. Brero A, Easwaran HP, Nowak D, Grunewald I, Cremer T, Leonhardt H, Cardoso MC, J Cell Biol 2005 169 733 743 10.1083/jcb.200502062 15939760 (Pubitemid 41002879)
54. Pax7 is required for the specification of myogenic satellite cells. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA, Cell 2000 102 777 786 10.1016/S0092-8674(00)00066-0 11030621
55. Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Lepper C, Conway SJ, Fan CM, Nature 2009 460 627 631 10.1038/nature08209 19554048
56. HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3. Magnaghi P, Roberts C, Lorain S, Lipinski M, Scambler PJ, Nat Genet 1998 20 74 77 10.1038/1739 9731536 (Pubitemid 28410349)
57. Distinct factors control histone variant H3.3 localization at specific genomic regions. Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S, Dewell S, Law M, Guo X, Li X, Wen D, Chapgier A, DeKelver RC, Miller JC, Lee YL, Boydston EA, Holmes MC, Gregory PD, Greally JM, Rafii S, Yang C, Scambler PJ, Garrick D, Gibbons RJ, Higgs DR, Cristea IM, Urnov FD, Zheng D, Allis CD, Cell 2010 140 678 691 10.1016/j.cell.2010.01.003 20211137
58. Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription. Ng RK, Gurdon JB, Nat Cell Biol 2008 10 102 109 10.1038/ncb1674 18066050
59. Myogenic transcriptional activation of MyoD mediated by replication-independent histone deposition. Yang JH, Song Y, Seol JH, Park JY, Yang YJ, Han JW, Youn HD, Cho EJ, Proc Natl Acad Sci USA 2011 108 85 90 10.1073/pnas.1009830108 21173268
60. Epigenetic therapy of leukemia: an update. Jain N, Rossi A, Garcia-Manero G, Int J Biochem Cell Biol 2009 41 72 80 10.1016/j.biocel.2008.10.006 18948224
61. Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment. Colussi C, Illi B, Rosati J, Spallotta F, Farsetti A, Grasselli A, Mai A, Capogrossi MC, Gaetano C, Pharmacol Res 2010 62 3 10 10.1016/j.phrs.2010.02.014 20227503
62. Histone modification therapy of cancer. Biancotto C, Frige G, Minucci S, Adv Genet 2010 70 341 386 full-text 20920755
63. Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group. Gotze K, Platzbecker U, Giagounidis A, Haase D, Lubbert M, Aul C, Ganser A, Germing U, Hofmann WK, Ann Hematol 2010 89 841 850 10.1007/s00277-010-1015-0 20567826
64. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, Parente V, Fortuni S, Straino S, Sampaolesi M, Di Padova M, Illi B, Gallinari P, Steinkuhler C, Capogrossi MC, Sartorelli V, Bottinelli R, Gaetano C, Puri PL, Nat Med 2006 12 1147 1150 10.1038/nm1479 16980968 (Pubitemid 44527349)
65. Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy. Colussi C, Gurtner A, Rosati J, Illi B, Ragone G, Piaggio G, Moggio M, Lamperti C, D'Angelo G, Clementi E, Minetti G, Mozzetta C, Antonini A, Capogrossi MC, Puri PL, Gaetano C, FASEB J 2009 23 2131 2141 10.1096/fj.08-115618 19264835
66. Selective inhibition of BET bromodomains. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE, Nature 2010 468 1067 1073 10.1038/nature09504 20871596
67. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor. Beltran AS, Sun X, Lizardi PM, Blancafort P, Mol Cancer Ther 2008 7 1080 1090 10.1158/1535-7163.MCT-07-0526 18483297
68. The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice. Di Certo MG, Corbi N, Strimpakos G, Onori A, Luvisetto S, Severini C, Guglielmotti A, Batassa EM, Pisani C, Floridi A, Benassi B, Fanciulli M, Magrelli A, Mattei E, Passananti C, Hum Mol Genet 2010 19 752 760 10.1093/hmg/ddp539 19965907
69. A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts. Wilber A, Tschulena U, Hargrove PW, Kim YS, Persons DA, Barbas CF, Nienhuis AW, Blood 2010 115 3033 3041 10.1182/blood-2009-08- 240556 20190190
70. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Sacco A, Mourkioti F, Tran RK, Choi J, Llewellyn M, Kraft P, Shkreli M, Delp S, Pomerantz JH, Artandi SE, Blau HM, Cell 2010 143 1059 1071 10.1016/j.cell.2010.11.039 21145579
71. Repression of human telomerase reverse transcriptase using artificial zinc finger transcription factors. Sohn JH, Yeh BI, Choi JW, Yoon J, Namkung J, Park KK, Kim HW, Mol Cancer Res 2010 8 246 253 10.1158/1541-7786.MCR-09-0141 20145034